A perspective on the selection of unrelated donors and cord blood units for transplantation

Blood

Volumn 120, Issue 2, 2012, Pages 259-265

  Spellman, Stephen R ^a   Eapen, Mary ^b   Logan, Brent R ^b   Mueller, Carlheinz ^c   Rubinstein, Pablo ^d   Setterholm, Michelle I ^e   Woolfrey, Ann E ^f   Horowitz, Mary M ^b   Confer, Dennis L ^e   Hurley, Carolyn K ^g  

^a CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c German National Bone Marrow Registry   (Germany)

^d NEW YORK BLOOD CENTER   (United States)

^e NATIONAL MARROW DONOR PROGRAM   (United States)

^f Fred Hutchinson Cancer Research Center   (United States)

^g GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LEUKEMIA; CHILDHOOD LEUKEMIA; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CORD BLOOD STEM CELL TRANSPLANTATION; DONOR SELECTION; ETHNICITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; MYELODYSPLASTIC SYNDROME; NATURAL KILLER CELL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RACE; REFRACTORY ANEMIA; REVIEW; SENSITIZATION; TREATMENT OUTCOME; UNRELATED DONORS;

EID: 84864144424     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-03-379032     Document Type: Review

References (52)

1. Hurley CK, Baxter Lowe LA, Logan B, et al. National Marrow Donor Program HLA-matching guidelines for unrelated marrow transplants. Biol Blood Marrow Transplant. 2003;9(10):610-615. (Pubitemid 38351780)
2. Bray RA, Hurley CK, Kamani NR, et al. National Marrow Donor Program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants. Biol Blood Marrow Transplant. 2008;14(S9):45-53.
3. Morishima Y, Sasazuki T, Inoki H, et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood. 2002;99(11):4200-4206. (Pubitemid 35332066)
4. Petersdorf EW, Gooley TA, Anasetti C, et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood. 1998;92(10):3515-3520. (Pubitemid 28525174)
5. Petersdorf EW, Gooley T, Malkki M, et al. The biological significance of HLA-DP gene variation in haematopoietic cell transplantation. Br J Haematol. 2001;112(4):988-994. (Pubitemid 32322927)
6. Petersdorf EW, Anasetti C, Martin PJ, et al. Limits of HLA mismatching in unrelated hematopoietic cell transplantation. Blood. 2004;104(9):2976-2980. (Pubitemid 39434990)
7. Petersdorf EW, Gooley T, Malkki M, Horowitz M, et al. Clinical significance of donor-recipient HLA matching on survival after myeloablative hematopoietic cell transplantation from unrelated donors. Tissue Antigens. 2007;69(S1):25-30. (Pubitemid 46625843)
8. Flomenberg N, Baxter-Lowe LA, Confer D, et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood. 2004;104(7):1923-1930. (Pubitemid 39297840)
9. Lee SJ, Klein J, Haagenson M, et al. Highresolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood. 2007;110(13):4576-4583. (Pubitemid 351377826)
10. Petersdorf EW. Optimal HLA matching in hematopoietic cell transplantation. Curr Opin Immunol. 2008;20(5):588-593.
11. Shaw BE, Gooley TA, Malkki M, et al. The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. Blood. 2007;110(13):4560- 4566. (Pubitemid 351377824)
12. Zino E, Frumento G, Marktel S, et al. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. Blood. 2004;103(4):1417-1424. (Pubitemid 38168657)
13. Fleischhauer K, Shaw BE, Gooley T, et al. Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study. Lancet Oncol. 2012;13(4):366-374.
14. Crocchiolo R, Zino E, Vago L, et al. Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation. Blood. 2009;114(7):1437-1444.
15. Fernandez-Vina M, Klein J, Haagenson M, et al. The clinical significance of matching for alleles at the low expression HLA loci DP, DQ and DRB3/ 4/5 in unrelated hematopoietic stem cell transplantation [abstract]. Blood (ASH Annual Meeting Abstracts). 2008;112(11):Abstract 561.
16. Woolfrey A, Klein JP, Haagenson M, et al. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation. Biol Blood Marrow Transplant. 2011;17(6):885-892.
17. Eapen M, Rocha V, Sanz G, et al. Effect of graft source on unrelated donor haemopoietic stemcell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol. 2010;11(7):653-660.
18. Cohen YC, Scaradavou A, Stevens CE, et al. Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries. Bone Marrow Transplant. 2011;46(1):70-76.
19. Eapen M, Rubinstein P, Zhang MJ, et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet. 2007;369(3577):1947-1954. (Pubitemid 46874578)
20. Laughlin MJ, Eapen M, Rubinstein P, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004;351(22):2265-2275. (Pubitemid 39552742)
21. Prasad VK, Mendizabal A, Parikh SH, et al. Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. Blood. 2008;112(7):2979-2989.
22. Escolar ML, Poe MD, Provenzale JM, et al. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med. 2005;352(20):2069-2081. (Pubitemid 40664308)
23. Kamani N, Spellman S, Hurley CK, et al. State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants. Biol Blood Marrow Transplant. 2008;14(1):1-6. (Pubitemid 350286749)
24. Barker JN, Scaradavou A, Stevens CE. Combined effect of total nucleated cell dose and HLA match on transplantation outcome in 1061 cord blood recipients with hematologic malignancies. Blood. 2010;115(9):1843-1849.
25. Eapen M, Klein JP, Sanz GF, et al. Effect of donor-recipient HLA matching at HLAA, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis. Lancet Oncol. 2011;12(13):1214-1221.
26. Brunstein CG, Fuchs EJ, Carter SL, et al. Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts. Blood. 2011;118(2):282-288.
27. Hurley CK, Oudshoorn M, Setterholm M. Donor registries and search strategies. In: Christiansen FT, Tait BD, eds. Methods in Molecular Biology, Vol 882: Immunogenetics. New York, NY: Humana Press; 2012.
28. Oudshoorn M, van Leeuwen A, vd Zanden HG, van Rood JJ. Bone Marrow Donors Worldwide: a successful exercise in international cooperation. Bone Marrow Transplant. 1994;14(1):3-8.
29. Spellman S, Bray R, Rosen-Bronson S, et al. The detection of donor-directed, HLA-specific alloantibodies in recipients of unrelated hematopoietic cell transplantation is predictive of graft failure. Blood. 2010;115(13):2704-2708.
30. Ciurea SO, Thall PF, Wang X, et al. Donor-specific anti-HLAAbs and graft failure in matched unrelated donor hematopoietic stem cell transplantation. Blood. 2011;118(22):5957-5964.
31. Nunes E, Heslop H, Fernandez-Vina M, et al. Definitions of histocompatibility typing terms. Blood. 2011;118(23):e180-e183.
32. Cano P, Klitz W, Mack SJ, et al. Common and well-documented HLA alleles: report of the Ad- Hoc committee of the American Society for Histocompatiblity and Immunogenetics. Hum Immunol. 2007;68(5):392-417. (Pubitemid 46616982)
33. Xiao Y, Lazaro AM, Masaberg C, et al. Evaluating the potential impact of mismatches outside the antigen recognition site in unrelated hematopoietic stem cell transplantation: HLA-DRB1&z.ast;1454 and DRB1&z.ast;140101. Tissue Antigens. 2009;73(6): 595-598.
34. Wade JA, Hurley CK, Takemoto SK, et al. HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation. Blood. 2007;109(9):4064-4070. (Pubitemid 46641762)
35. Duquesnoy R, Spellman S, Haagenson M, et al. HLAMatchmaker-defined triplet matching is not associated with better survival rates of patients with class I HLA allele mismatched hematopoietic cell transplants from unrelated donors. Biol Blood Marrow Transplant. 2008;14(9):1064-1071.
36. Askar M, Sobecks R, Morishima Y, et al. Predictions in the face of clinical reality: HistoCheck versus high-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease. Biol Blood Marrow Transplant. 2011; 17(9):1409-1415.
37. Spellman S, Klein J, Haagenson M, et al. Scoring HLA class I mismatches by HistoCheck does not predict clinical outcome in unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2012;18(5):739-746.
38. Morishima Y, Kawase T, Malkki M, Petersdorf EW. Effect of HLA-A2 allele disparity on clinical outcome in hematopoietic cell transplantation from unrelated donors. Tissue Antigens. 2007;69(S1):31-35. (Pubitemid 46625844)
39. Baxter-Lowe LA, Maiers M, Spellman SR, et al. HLA-A disparities illustrate challenges for ranking the impact of HLA mismatches on bone marrow transplant outcomes in the United States. Biol Blood Marrow Transplant. 2009;15(8):971-981.
40. van Rood JJ, Loberiza FR Jr, Zhang MJ, et al. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. Blood. 2002;99(5):1572-1577.
41. van Rood JJ, Stevens CE, Smits J, et al. Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies. Proc Natl Acad Sci U S A. 2009;106(47):19952-19957.
42. Rocha V, Purtill D, Zhang M, et al. Impact of matching at noninherited maternal antigens on outcomes after 5/6 or 4/6 HLA-mismatched unrelated cord blood transplantation for malignant haematological disease: a matched pair analysis on behalf of Eurocord, Netcord, NMDP, CIBMTR [abstract]. Bone Marrow Transplant. 2011;46(S1): S2. Abstract O115.
43. Brady C, Brown M, Eapen M, et al. The influence of HLA antigen/allele frequency on access to non-inherited maternal antigens (NIMA) for recipients of cord blood transplant. Paper presented at the 9th Annual Umbilical Cord Blood Symposium, San Francisco, CA, June 23, 2011.
44. Taylor PA, Ehrhardt MJ, Roforth MM, et al. Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients. Blood. 2007;109(3): 1307-1315. (Pubitemid 46220684)
45. Ottinger HD, Rebmann V, Pfeiffer KA, et al. Positive serum crossmatch as predictor for graft failure in HLA-mismatched allogeneic blood stem cell transplantation. Transplantation. 2002;73(8): 1280-1285. (Pubitemid 34454276)
46. Takanashi M, Atsuta Y, Fujiwara K, et al. The impact of anti-HLA antibodies on unrelated cord blood transplantations. Blood. 2010;116(15): 2839-2846.
47. Cutler C, Kim HT, Sun L, et al. Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation. Blood. 2011;118(25):6691-6697.
48. Kollman C, Howe CW, Anasetti C, et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood. 2001; 98(7):2043-2051.
49. Ruggeri L, Capanni M, Urgani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295(5562):2097-2100. (Pubitemid 34229476)
50. Grzywacz B, Miller JS, Verneris MR. Use of natural killer cells as immunotherapy for leukaemia. Best Pract Res Clin Haematol. 2008;21(3):467-483.
51. Witt CS. The influence of NK alloreactivity on matched unrelated donor and HLA identical sibling haematopoietic stem cell transplantation. Curr Opin Immunol. 2009;21(5):531-537.
52. Willemze R, Ruggeri A, Purtill D, et al. Is there an impact of killer cell immunoglobulin-like receptors and KIR-ligand incompatibilities on outcomes after unrelated cord blood stem cell transplantation? Best Pract Res Clin Haematol. 2010;23(2):283-290.